As part of the Net Zero Program, Ypsomed conducts lifecycle assessments in accordance with ISO 14040/44 standards, using an established methodology verified by independent third parties
The current pilot data, along with the weight loss findings from the main phase two trial, further support the use of retatrutide in people with NASH. Julio Rosenstock, MD, Principal Investigator and Director of Velocity Clinical Research at Medical City and Clinical Professor of Medicine at the University of Texas (UT) Southwestern, discussed the efficacy and safety results from the Retatrutide for People with Type 2 Diabetes Phase 2 Study
Lower blood volume means your heart works harder to deliver oxygen to tissues
Table 1 Demonstrated primary effects of the major GLP-1-stimulating receptors
And the clinical outcomes at matching timepoints reveal a gap that keeps widening with every new dataset published
Your order reserves stock from the incoming batch and ships as soon as the batch is available